Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Feb;25(2):169–177. doi: 10.1111/j.1365-2125.1988.tb03288.x

Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.

M A van Baak 1, F M Koene 1, F T Verstappen 1
PMCID: PMC1386471  PMID: 2896013

Abstract

1. The effects of atenolol administration on maximal exercise capacity and exercise haemodynamics have been compared in eight normotensive and eight mildly hypertensive subjects, matched for sex, age, body weight, and maximal oxygen uptake, and familiar with maximal exercise testing. 2. Supine and exercise blood pressure, and exercise total peripheral resistance were significantly higher, and exercise cardiac output was significantly lower in the hypertensive than in the normotensive subjects. 3. Administration of atenolol (1 X 100 mg day-1) for 3 days reduced supine and exercise systolic blood pressure, heart rate, and cardiac output, and increased exercise stroke volume. Supine and exercise diastolic blood pressure and exercise total peripheral resistance were unaffected by atenolol. The effects of atenolol did not differ in the normotensive and the hypertensive subjects. 4. Maximal work load, maximal oxygen uptake, and maximal heart rate were reduced to a similar extent in normotensive and hypertensive subjects during atenolol treatment. 5. It is concluded that there is no difference in the effects of short-term atenolol administration on exercise haemodynamics and maximal exercise capacity in normotensive and mildly hypertensive subjects.

Full text

PDF
169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. D., Bye P. T., Perry C. P., Hamor G. P., Theobald G., Nyberg G. Limitation of work performance in normal adult males in the presence of beta-adrenergic blockade. Aust N Z J Med. 1979 Oct;9(5):515–520. doi: 10.1111/j.1445-5994.1979.tb03387.x. [DOI] [PubMed] [Google Scholar]
  2. COLLIER C. R. Determination of mixed venous CO2 tensions by rebreathing. J Appl Physiol. 1956 Jul;9(1):25–29. doi: 10.1152/jappl.1956.9.1.25. [DOI] [PubMed] [Google Scholar]
  3. DEFARES J. G. Determination of PvCO2 from the exponential CO2 rise during rebreathing. J Appl Physiol. 1958 Sep;13(2):159–164. doi: 10.1152/jappl.1958.13.2.159. [DOI] [PubMed] [Google Scholar]
  4. Ekblom B., Goldbarg A. N., Kilbom A., Astrand P. O. Effects of atropine and propranolol on the oxygen transport system during exercise in man. Scand J Clin Lab Invest. 1972 Sep;30(1):35–42. doi: 10.3109/00365517209081087. [DOI] [PubMed] [Google Scholar]
  5. Epstein S., Robinson B. F., Kahler R. L., Braunwald E. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest. 1965 Nov;44(11):1745–1753. doi: 10.1172/JCI105282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ergometrie--Empfehlungen zur Durchführung und Bewertung ergometrischer Untersuchungen. Klin Wochenschr. 1985 Jul 15;63(14):651–677. [PubMed] [Google Scholar]
  7. Folgering H., van Bussel M. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol. Eur J Clin Pharmacol. 1980 Oct;18(3):225–229. doi: 10.1007/BF00563003. [DOI] [PubMed] [Google Scholar]
  8. Franz I. W., Lohmann F. W. Der Einfluss einer chronischen sog. kardioselektiven und nichtkardioselektiven beta-Rezeptoren-Blockade auf den Blutdruck, die 02-Aufnahme und den Kohlenhydratstoffwechsel. Ergometrische Untersuchungen bein Hochdruckkranken. Z Kardiol. 1979 Jul;68(7):503–509. [PubMed] [Google Scholar]
  9. Franz I. W., Lohmann F. W., Koch G. Effects of chronic antihypertensive treatment with acebutolol and pindolol on blood pressures, plasma catecholamines, and oxygen uptake at rest and during submaximal and maximal exercise. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):180–186. doi: 10.1097/00005344-198203000-00004. [DOI] [PubMed] [Google Scholar]
  10. Franz I. W., Lohmann F. W., Koch G. Oxygen uptake and plasma catecholamines during submaximal and maximal exercise after long-term beta-receptor blockade. Int J Sports Med. 1985 Aug;6(4):202–206. doi: 10.1055/s-2008-1025840. [DOI] [PubMed] [Google Scholar]
  11. Frisk-Holmberg M., Jorfeldt L., Juhlin-Dannfelt A. Metabolic effects in muscle during antihypertensive therapy with beta 1- and beta 1/beta 2-adrenoceptor blockers. Clin Pharmacol Ther. 1981 Nov;30(5):611–618. doi: 10.1038/clpt.1981.212. [DOI] [PubMed] [Google Scholar]
  12. Frisk-Holmberg M., Juhlin-Dannfelt A., Aström H. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man. Clin Physiol. 1985 Jun;5(3):231–242. [PubMed] [Google Scholar]
  13. Hansson B. G., Dymling J. F., Hedeland H., Hulthén U. L. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions. Eur J Clin Pharmacol. 1977 Apr 20;11(4):239–245. doi: 10.1007/BF00607671. [DOI] [PubMed] [Google Scholar]
  14. Hughson R. L., MacFarlane B. J. Effect of oral propranolol on the anerobic threshold and maximum exercise performance in normal man. Can J Physiol Pharmacol. 1981 Jun;59(6):567–573. doi: 10.1139/y81-085. [DOI] [PubMed] [Google Scholar]
  15. Jones N. L., Campbell E. J., McHardy G. J., Higgs B. E., Clode M. The estimation of carbon dioxide pressure of mixed venous blood during exercise. Clin Sci. 1967 Apr;32(2):311–327. [PubMed] [Google Scholar]
  16. Kaiser P., Tesch P. A., Frisk-Holmberg M., Juhlin-Dannfelt A., Kaijser L. Effect of beta 1-selective and non-selective beta-blockade on work capacity and muscle metabolism. Clin Physiol. 1986 Apr;6(2):197–207. doi: 10.1111/j.1475-097x.1986.tb00069.x. [DOI] [PubMed] [Google Scholar]
  17. Kindermann W., Scheerer W., Salas-Fraire O., Biro G., Wölfing A. Verhalten der körperlichen Leistungsfähigkeit und des Metabolismus unter akuter Beta 1- und Beta 1/2-Blockade. Z Kardiol. 1984 Jun;73(6):380–387. [PubMed] [Google Scholar]
  18. Leenen F. H., Coenen C. H., Zonderland M., Maas A. H. Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther. 1980 Jul;28(1):12–21. doi: 10.1038/clpt.1980.124. [DOI] [PubMed] [Google Scholar]
  19. Lijnen P. J., Amery A. K., Fagard R. H., Reybrouck T. M., Moerman E. J., De Schaepdryver A. F. The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise. Br J Clin Pharmacol. 1979 Feb;7(2):175–181. doi: 10.1111/j.1365-2125.1979.tb00918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pearson S. B., Banks D. C., Patrick J. M. The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol. 1979 Aug;8(2):143–148. doi: 10.1111/j.1365-2125.1979.tb05812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reybrouck T., Amery A., Billiet L. Hemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol Respir Environ Exerc Physiol. 1977 Feb;42(2):133–138. doi: 10.1152/jappl.1977.42.2.133. [DOI] [PubMed] [Google Scholar]
  22. Stanley W. C., Gertz E. W., Wisneski J. A., Neese R. A., Morris D. L., Brooks G. A. Lactate extraction during net lactate release in legs of humans during exercise. J Appl Physiol (1985) 1986 Apr;60(4):1116–1120. doi: 10.1152/jappl.1986.60.4.1116. [DOI] [PubMed] [Google Scholar]
  23. Tesch P. A., Kaiser P. Effects of beta-adrenergic blockade on O2 uptake during submaximal and maximal exercise. J Appl Physiol Respir Environ Exerc Physiol. 1983 Apr;54(4):901–905. doi: 10.1152/jappl.1983.54.4.901. [DOI] [PubMed] [Google Scholar]
  24. Verstappen F. T., van Baak M. A. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker. Eur J Appl Physiol Occup Physiol. 1987;56(6):712–718. doi: 10.1007/BF00424815. [DOI] [PubMed] [Google Scholar]
  25. Wennevold A. The origin of the innocent "vibratory" murmur studied with intracardiac phonocardiography. Acta Med Scand. 1967 Jan;181(1):1–5. doi: 10.1111/j.0954-6820.1967.tb07218.x. [DOI] [PubMed] [Google Scholar]
  26. Wilmore J. H., Freund B. J., Joyner M. J., Hetrick G. A., Hartzell A. A., Strother R. T., Ewy G. A., Faris W. E. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise. Am J Cardiol. 1985 Apr 26;55(10):135D–141D. doi: 10.1016/0002-9149(85)91070-7. [DOI] [PubMed] [Google Scholar]
  27. van Baak M. A., Böhm R. O., Arends B. G., van Hooff M. E., Rahn K. H. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise. Int J Sports Med. 1987 Oct;8(5):342–347. doi: 10.1055/s-2008-1025681. [DOI] [PubMed] [Google Scholar]
  28. van Baak M. A., Verstappen F. T., Oosterhuis B. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion. Eur J Clin Pharmacol. 1986;30(4):399–406. doi: 10.1007/BF00607951. [DOI] [PubMed] [Google Scholar]
  29. van Baak M., Jennen W., Verstappen F. T. Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol. Eur J Clin Pharmacol. 1985;28(2):143–148. doi: 10.1007/BF00609682. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES